Habib R. Ansari
West Virginia University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Habib R. Ansari.
American Journal of Physiology-heart and Circulatory Physiology | 2009
Habib R. Ansari; Bunyen Teng; Ahmed Nadeem; Kevin Roush; Karen H. Martin; Jurgen Schnermann; S. Jamal Mustafa
The A(1) adenosine receptor (A(1)AR) is coupled to G(i)/G(o) proteins, but the downstream signaling pathways in smooth muscle cells are unclear. This study was performed in coronary artery smooth muscle cells (CASMCs) isolated from the mouse heart [A(1)AR wild type (A(1)WT) and A(1)AR knockout (A(1)KO)] to delineate A(1)AR signaling through the PKC pathway. In A(1)WT cells, treatment with (2S)-N(6)-(2-endo-norbornyl)adenosine (ENBA; 10(-5)M) increased A(1)AR expression by 150%, which was inhibited significantly by the A(1)AR antagonist 1,3-dipropyl-8-cyclopentylxanthine (10(-6)M), but not in A(1)KO CASMCs. PKC isoforms were identified by Western blot analysis in the cytosolic and membrane fractions of cell homogenates of CASMCs. In A(1)WT and A(1)KO cells, significant levels of basal PKC-alpha were detected in the cytosolic fraction. Treatment with the A(1)AR agonist ENBA (10(-5)M) translocated PKC-alpha from the cytosolic to membrane fraction significantly in A(1)WT but not A(1)KO cells. Phospholipase C isoforms (betaI, betaIII, and gamma(1)) were analyzed using specific antibodies where ENBA treatment led to the increased expression of PLC-betaIII in A(1)WT CASMCs while having no effect in A(1)KO CASMCs. In A(1)WT cells, ENBA increased PKC-alpha expression and p42/p44 MAPK (ERK1/2) phospohorylation by 135% and 145%, respectively. These effects of ENBA were blocked by Gö-6976 (PKC-alpha inhibitor) and PD-98059 (p42/p44 MAPK inhibitor). We conclude that A(1)AR stimulation by ENBA activates the PKC-alpha signaling pathway, leading to p42/p44 MAPK phosphorylation in CASMCs.
Current protocols in pharmacology | 2009
S. Jamal Mustafa; Habib R. Ansari; Worku Abebe
P1 purinoceptors, or adenosine (ADO) receptors, mediate the biological effects of the endogenous nucleoside, ADO and its analogs. ADO works through four receptor subtypes: A1, A2A, A2B, and A3. Isolated tissue assays used for the pharmacological characterization of ADO receptors based on functional responses are described in this unit. The guinea pig atrium, pig coronary artery, guinea pig aorta ,and mouse aorta have been used for the characterization of ADO receptor subtypes. Curr. Protoc. Pharmacol. 45:4.7.1‐4.7.13.
American Journal of Physiology-heart and Circulatory Physiology | 2007
Habib R. Ansari; Ahmed Nadeem; M.A. Hassan Talukder; Shilpa Sakhalkar; S. Jamal Mustafa
American Journal of Physiology-lung Cellular and Molecular Physiology | 2007
Ahmed Nadeem; Ming Fan; Habib R. Ansari; Catherine Ledent; S. Jamal Mustafa
American Journal of Physiology-heart and Circulatory Physiology | 2007
Habib R. Ansari; Ahmed Nadeem; Stephen L. Tilley; S. Jamal Mustafa
American Journal of Physiology-heart and Circulatory Physiology | 2006
Bunyen Teng; Habib R. Ansari; Peter J. Oldenburg; Jurgen Schnermann; S. Jamal Mustafa
American Journal of Physiology-heart and Circulatory Physiology | 2008
Mohammed Nayeem; Samuel M. Poloyac; John R. Falck; Darryl C. Zeldin; Catherine Ledent; Dovenia S. Ponnoth; Habib R. Ansari; S. Jamal Mustafa
The FASEB Journal | 2007
Mohammed Nayeem; John R. Falck; Catherine Ledent; Dovenia S. Ponnoth; Habib R. Ansari; S P Sakhalkar; S. Mustafa
The FASEB Journal | 2008
Habib R. Ansari; Bunyen Teng; Ahmed Nadeem; Jurgen Schnermann; S. Jamal Mustafa
Archive | 2008
Mohammed A. Nayeem; Samuel M. Poloyac; John R. Falck; Darryl C. Zeldin; Habib R. Ansari; S. Jamal Mustafa; Robert C. Byrd